Skip to content

Continuous Pectoral Nerve Block in Breast Cancer Surgery

The Effect of Continuous Pectoral Nerve Block on Postoperative Analgesia Consumption in Breast Cancer Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04036370
Enrollment
48
Registered
2019-07-29
Start date
2019-07-30
Completion date
2019-11-15
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Surgery, Nerve Blocks, Postoperative Pain

Keywords

pectoral nerve block (pecs block), breast cancer, postoperative pain, numeric rating scale score (NRS score)

Brief summary

The purpose of the study is to evaluate the effect of continuous pectoral nerve block on postoperative analgesia consumption in breast cancer surgery.

Detailed description

Pectoral nerve block has been developed as an alternative to thoracic paravertebral and/or thoracic epidural blocks in recent years. It is frequently applied for postoperative analgesia in breast cancer surgery.

Interventions

PROCEDUREPECS group

Pecs block performed using ultrasound guidance. Standard pain follow up and monitorization will be performed.

OTHERControl group

Standard pain follow up and monitorization will be performed.

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Randomised Controlled

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiology (ASA) I-II * 18-65 years * Body mass index (BMI) ≤40 kg/m2 * Elective breast cancer surgery

Exclusion criteria

* ASA ≥4 * under 18 years of age or over 65 years of age * declining to give written informed consent * history of allergy to the local anesthetics * contraendications of peripheral block or local anesthetic infiltration (local infection, coagulopathy, etc) * history of breast surgery * treatment due to psychiatric disorder * history of treatment for chronic pain * history of nerve blocks in order to treat postoperative pain

Design outcomes

Primary

MeasureTime frameDescription
analgesia consumption12 hourspostoperative 12 hours

Secondary

MeasureTime frameDescription
analgesia consumptionduring the surgeryintraoperative
postoperative Numeric Rating Scale (NRS) score0, 1, 3, 6, 9, 12 hourspostoperative pain assessment will be performed using NRS score (NRS 0=no pain, NRS 10= most severe possible). The NRS scores will be recorded at postoperative 0, 1, 3, 6, 9, 12 hours

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026